NCT00408135View on ClinicalTrials.gov

Japanese Study Evaluating Safety, Efficacy and Acceptability of Telithromycin in Children With Infections

PHASE3CompletedINTERVENTIONAL
Enrollment

111

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

May 31, 2005

Study Completion Date

May 31, 2005

Conditions
InfectionsChild
Interventions
DRUG

telithromycin (HMR3647)

Trial Locations (1)

Unknown

Sanofi-Aventis, Tokyo

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY